首页> 外国专利> PANCREATIC INSULIN-PRODUCING BETA-CELL LINES DERIVED FROM HUMAN PLURIPOTENT STEM CELLS

PANCREATIC INSULIN-PRODUCING BETA-CELL LINES DERIVED FROM HUMAN PLURIPOTENT STEM CELLS

机译:从人多能干细胞中提取胰腺产生的β-细胞系

摘要

Production of beta-cells from stem cells from pluripotent stem cells have always been significantly lacking in at least one of the following properties: 1) functional properties related to insulin-production and glucose signaling response, 2) mature phenotype such as biochemical markers or cell structures, 3) efficiency in production of differentiated cells. Described herein is multistep differentiation protocol which substantially overcomes all of the existing limitations. Pluripotent stem cells, including induced pluripotent stem cells (iPSCs), and embryonic stem cells (ESCs) can be differentiated using an embryoid body (EB) formation step, followed by B maturation via endothelial cells (EC) co-culturing and incubation with a sequential series of bone morphogenic protein (BMP)-related growth factor cocktails. The resulting cells displayed functional properties, including insulin-production and glucose signaling response, and mature phenotype of C-peptide expression.
机译:从多能干细胞产生的干细胞中,β-细胞的生产一直非常缺乏以下特性之一:1)与胰岛素产生和葡萄糖信号反应有关的功能特性,2)成熟的表型,如生化标记或细胞结构,3)产生分化细胞的效率。本文描述的是一种多步区分协议,该协议基本克服了所有现有限制。多能干细胞,包括诱导多能干细胞(iPSC)和胚胎干细胞(ESC),可以使用胚状体(EB)形成步骤进行区分,然后通过内皮细胞(EC)共同培养B成熟并与骨形态发生蛋白(BMP)相关生长因子混合物的连续序列。所得细胞显示出功能性质,包括胰岛素产生和葡萄糖信号传导应答,以及C肽表达的成熟表型。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号